What is the recommended flucloxacillin dose per kilogram of body weight for treating infections?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 5, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Flucloxacillin Dosing Per Kilogram

For pediatric patients beyond the neonatal period, flucloxacillin should be dosed at 50 mg/kg every 6 hours IV for serious staphylococcal infections such as necrotizing fasciitis or bloodstream infections 1, 2.

Dosing by Age Group

Neonates and Premature Infants

  • Premature neonates (gestational age 26-29 weeks): 50 mg/kg IV, but dosing frequency must be adjusted based on age:

    • First 2 weeks of life: every 12 hours (due to prolonged half-life of ~73 hours at birth, decreasing to ~46 hours by day 12) 3
    • After 2 weeks: transition to more frequent dosing
  • Term neonates: Recent pharmacokinetic data suggests 25 mg/kg every 4 hours for all neonates regardless of gestational age when treating Staphylococcus aureus infections, as the current standard dosing (25-50 mg/kg every 8-12 hours) resulted in subtherapeutic levels in 31% of patients 4

Children Beyond Neonatal Period

  • Standard dosing: 50 mg/kg/dose every 6 hours IV for serious infections 1, 2
  • This is the recommended dose from IDSA guidelines for treating staphylococcal necrotizing infections
  • Maximum single dose should not exceed adult dosing equivalents

Adults

  • Standard dosing: 1-2 g every 4 hours IV 1, 2
  • For severe infections: 2 g every 4 hours is preferred
  • This translates to approximately 25-30 mg/kg every 4 hours for a 70 kg adult

Critical Considerations

Common pitfall: The evidence shows significant underdosing occurs with traditional neonatal regimens. The terminal half-life in neonates (4.6 hours) is much longer than adults, and clearance is substantially reduced (0.18 L/kg/h in neonates vs higher in adults) 3, 4. However, protein binding is also lower in neonates (86.3%) and even lower in critically ill patients (resulting in 11.5-16.7% unbound fraction vs ~5% in healthy adults) 5.

Temperature stability warning: If using outpatient parenteral therapy with elastomeric pumps, flucloxacillin solutions (50 mg/mL) maintain >92% potency for 24 hours at 33°C, but this drops to <85% at 37°C. Initial pH must be >5.9 to prevent precipitation 6.

Renal adjustment: Flucloxacillin clearance correlates with renal function. In neonates, renal clearance is only 0.182 mL/min/kg compared to higher values in adults 3. However, the correlation with gestational age and creatinine is low enough that fixed dosing by age is more practical than individual adjustment 4.

Target concentrations: Aim for time above MIC (T>MIC) >40% of the dosing interval. For S. aureus (MIC 2.0 mg/L), this requires the aggressive dosing outlined above. For coagulase-negative staphylococci (MIC 0.25 mg/L), doses can be reduced to 10 mg/kg every 6 hours 4.

Related Questions

Should I use flucloxacillin for methicillin-sensitive Staphylococcus aureus (MSSA) pneumonia?
What is the recommended intravenous dosing regimen for flucloxacillin (including adult and pediatric doses, infusion time, renal adjustment, treatment duration, and contraindications) for methicillin‑susceptible Staphylococcus aureus infections?
What is the difference between cefazolin (Ancef) and cloxacillin (Tegopen) in terms of spectrum of activity and usage?
What antibiotic regimen is appropriate for cellulitis with abscess in a patient allergic to penicillins and levofloxacin (a fluoroquinolone) to cover Staphylococcus aureus?
Is cefepime an appropriate treatment for methicillin‑susceptible Staphylococcus aureus (MSSA) infection, and what are the recommended dose and duration in an adult with normal renal function?
What is the rationale for prescribing triple therapy with metformin, a sodium‑glucose co‑transporter‑2 (SGLT2) inhibitor, and a dipeptidyl peptidase‑4 (DPP‑4) inhibitor?
What is the significance of bilateral atrial enlargement on cardiac MRI in a patient with normal ventricles and occasional atrial tachycardia, and how should it be managed?
What are the diagnostic criteria and management recommendations for gastrointestinal tuberculosis?
Which myeloproliferative neoplasm should be considered in a patient presenting with splenomegaly?
Is saffron effective for managing female hormonal conditions such as premenstrual syndrome, and what dosage and safety precautions are recommended?
How should a first seizure in a 3-year-old child without fever be managed?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.